Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 10 04 2025] - (CGWL)
-
Highlander Silver Receives Conditional Approval to List on the TSX, Files Base Shelf Prospectus and Establishes ATM Program as Longer Term Financial Alternatives
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 09 04 2025] - (CGAML)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 09 04 2025] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Pacific Biosciences of California (PACB)
-
Travere Therapeutics (TVTX) PT Raised to $47 at Canaccord Genuity
-
Canaccord Genuity Starts BlackSky Technology Inc. (BKSY) at Buy
-
Canaccord Genuity Starts Intelligent Monitoring Group (IMB:AU) at Buy
-
Arrow Exploration Announces Operational Update
-
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
-
Alpha Exploration Closes First Tranche of Private Placement Financing
-
Lucid Diagnostics (LUCD) Announces Proposed Public Offering of Common Stock
-
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
-
Arras Minerals Closes Upsized $16.1 Million Financing
-
Tiny Announces Closing of $20 Million Bought Deal Offering of Subscription Receipts
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 08 04 2025] - (CGAML)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 08 04 2025] - (CGWL)
-
Form 8.3 - [ALLIANCE PHARMA PLC - 08 04 2025] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on EZCORP (EZPW)
-
Canaccord Genuity Reiterates Buy Rating on TELA Bio, Inc. (TELA)
-
Canaccord Genuity Starts Count Limited (CUP:AU) at Buy
-
Management Increasing Ownership in Amaroq Minerals and RSU Vesting Update
-
Maple Leaf Critical Minerals 2025 Enhanced Flow-Through Limited Partnership
-
Corsair Completes Sale of eurochange to The Western Union Company, Finalizes Exit from NoteMachine
-
Form 8.3 - [PURETECH HEALTH PLC - Opening Disclosure - 07 04 2025] - (CGAML)
-
Canaccord Genuity Reiterates Buy Rating on Clover Health (CLOV)
-
CVRx Inc (CVRX) PT Lowered to $18 at Canaccord Genuity
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $92 at Canaccord Genuity
-
Form 8.3 - [ALLIANCE PHARMA PLC - 07 04 2025] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 07 04 2025] - (CGWL)
-
Thor Explorations Announces Audited Financial and Operating Results for the Full Year and the Unaudited Three Months Ending December 31, 2024 and Maiden Dividend
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 04 04 2025] - (CGWL)
-
DigitalOcean (DOCN) PT Lowered to $45 at Canaccord Genuity
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 03 04 2025] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
-
Ninepoint Partners Announces Second Closing of Ninepoint 2025 Flow-Through Limited Partnership
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 02 04 2025] - (CGWL)
-
Dinan Capital Advisors Welcomes Michael Brill as Managing Director Leading Private Capital Markets
-
Snowline Gold Closes Fully Subscribed C$20 Million Financing Of Flow-Through Shares
-
Canaccord Genuity Reiterates Buy Rating on Rivian Automotive Inc (RIVN)
-
Canaccord Genuity Reiterates Buy Rating on Enovis Corp (ENOV)
-
Canaccord Genuity Reiterates Buy Rating on AngioDynamics (ANGO)
-
Sportradar Group AG (SRAD) PT Raised to $32 at Canaccord Genuity
-
BlackBerry Limited (BB) PT Lowered to $4.25 at Canaccord Genuity
-
Canaccord Genuity Upgrades Pine Cliff Energy Ltd. (PNE:CN) (PIFYF) to Buy
-
Tiny Announces Filing of Prospectus Supplement
-
Canaccord Genuity Reiterates Buy Rating on Tesla (TSLA), PT $404
-
Form 8.3 - [ALLIANCE PHARMA PLC - 01 04 2025] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 01 04 2025] - (CGWL)
-
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

